Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
OB ›
OBLONE
Trademark search for:
OBLONE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-03-17 — Application filed
2016-06-02 — Sn assigned for sect 66a subseq desig from ib
2016-06-02 — Application filed
2016-06-08 — Application filed
2016-06-14 — Application filed
2016-06-28 — Assigned to examiner
2016-06-28 — Final disposition recorded
2016-06-29 — Office action issued
2016-06-29 — Office action issued
2016-06-29 — Office action issued
2016-07-15 — Office action issued
2017-01-20 — Limitation of goods received from ib
2017-01-25 — Application abandoned
2017-01-25 — Application abandoned
2017-02-23 — Petition to revive-granted
2017-02-23 — Office action issued
2017-02-23 — Notice of revival - mailed
2017-02-23 — Teas petition to revive received
2017-03-10 — Assigned to lie
2017-03-14 — Correspondence received in law office
2017-03-14 — Teas/email correspondence entered
2017-03-30 — Office action issued
2017-03-30 — Office action issued
2017-03-30 — Office action issued
2017-04-10 — Limitation from the ib examined, no action is needed
2017-06-07 — Teas change of correspondence received
2017-06-07 — Teas request for reconsideration received
2017-06-07 — Correspondence received in law office
2017-06-07 — Teas/email correspondence entered
2017-06-07 — Approved for pub - principal register
2017-06-15 — Law office publication review completed
2017-06-28 — Notification of notice of publication e-mailed
2017-07-18 — Official gazette publication confirmation e-mailed
2017-07-18 — Published for opposition
2017-10-03 — Registered-principal register
2018-01-03 — Final disposition recorded
2018-01-18 — Final disposition recorded
2018-01-18 — Final disposition recorded
2018-02-16 — Final disposition recorded
2019-01-25 — Correction transaction received from ib
2019-02-05 — Correction from the ib examined, no action is needed
2022-10-03 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2024-04-19 — Cancelled section 71
2024-12-20 — Total invalidation of reg ext protection created
2025-02-17 — Final status recorded
2025-02-18 — Invalidation processed
2025-02-18 — Total invalidation of reg ext protection sent to ib
2025-03-21 — Total invalidation processed by the ib
2025-09-05 — Death of international registration
2025-09-05 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
BIOFARMA
F-92284 SURESNES CEDEX FR
BIOFARMA
F-92284 SURESNES CEDEX FR
BIOFARMA
F-92284 SURESNES CEDEX FR
Correspondent
Lisa Gates Baker&McKenzie LLP 300 E. Randolph St. Suite 5000 Chicago, IL 60601 UNITED STATES
Filing Details
Filing Date:
2016-03-17
Status Date:
2025-02-17
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.